KF
Therapeutic Areas
BioAge Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| BGE-102 | Cardiovascular Risk Reduction | Phase 1b/2a |
| Apelin Receptor Agonist | Obesity (Exercise Mimetic) | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| BGE-102 | Cardiovascular Risk Reduction | Phase 1b/2a |
| Apelin Receptor Agonist | Obesity (Exercise Mimetic) | Preclinical |